DD132349A5 - Verfahren zur herstellung neuer steroidverbindungen mit 19-staendiger sauerstoffunktion - Google Patents

Verfahren zur herstellung neuer steroidverbindungen mit 19-staendiger sauerstoffunktion

Info

Publication number
DD132349A5
DD132349A5 DD7700201351A DD20135177A DD132349A5 DD 132349 A5 DD132349 A5 DD 132349A5 DD 7700201351 A DD7700201351 A DD 7700201351A DD 20135177 A DD20135177 A DD 20135177A DD 132349 A5 DD132349 A5 DD 132349A5
Authority
DD
German Democratic Republic
Prior art keywords
producing new
steroid compounds
stage oxygen
oxygen function
new steroid
Prior art date
Application number
DD7700201351A
Other languages
English (en)
Inventor
Georg Anner
Hellmut Ueberwasser
Michel Biollaz
Peter Wieland
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU75936A external-priority patent/LU75936A1/xx
Priority claimed from LU76966A external-priority patent/LU76966A1/xx
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD132349A5 publication Critical patent/DD132349A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD7700201351A 1976-10-05 1977-10-04 Verfahren zur herstellung neuer steroidverbindungen mit 19-staendiger sauerstoffunktion DD132349A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU75936A LU75936A1 (de) 1976-10-05 1976-10-05
LU76966A LU76966A1 (de) 1977-03-17 1977-03-17

Publications (1)

Publication Number Publication Date
DD132349A5 true DD132349A5 (de) 1978-09-20

Family

ID=26640214

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700201351A DD132349A5 (de) 1976-10-05 1977-10-04 Verfahren zur herstellung neuer steroidverbindungen mit 19-staendiger sauerstoffunktion

Country Status (16)

Country Link
US (1) US4150127A (de)
JP (1) JPS5346952A (de)
AT (1) ATA705277A (de)
AU (1) AU512101B2 (de)
CA (1) CA1099701A (de)
DD (1) DD132349A5 (de)
DE (1) DE2744255A1 (de)
DK (1) DK142707B (de)
ES (1) ES462882A1 (de)
FI (1) FI58779C (de)
FR (1) FR2367079A1 (de)
IL (1) IL53058A0 (de)
NL (1) NL7710939A (de)
NO (1) NO773381L (de)
NZ (1) NZ185341A (de)
SE (1) SE7711094L (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
DE3326013A1 (de) * 1983-07-15 1985-01-24 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylen-17(alpha)-pregna-4,6-dien-21-carbonsaeuresalze, diese enthaltende pharmazeutische praeparate sowie verfahren zu deren herstellung
DE3330084A1 (de) * 1983-08-17 1985-03-07 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-alkoxycarbonyl-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone und deren 21-carbonsaeuresalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPH0425327Y2 (de) * 1985-11-08 1992-06-17
FR2656309B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical ethyle substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
CA2180548A1 (en) * 1994-01-06 1995-07-13 Masato Tanabe Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
WO2012107513A1 (en) * 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
CH708607A2 (fr) 2013-09-26 2015-03-31 Montres Breguet Sa Pièce d'horlogerie musicale ou à sonnerie.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058522A (en) * 1973-07-09 1977-11-15 Richter Gedeon Vegyeszeti Gyar Rt. Steroids effective against heavy-metal poisoning
US4028348A (en) * 1976-02-17 1977-06-07 Richter Gedeon Vegyeszeti Gyar Rt 6-Amino-5β,19-cycloandrostane derivatives

Also Published As

Publication number Publication date
DK142707C (de) 1981-10-05
FR2367079B1 (de) 1980-04-18
DE2744255A1 (de) 1978-04-06
FI58779C (fi) 1981-04-10
CA1099701A (en) 1981-04-21
ATA705277A (de) 1981-07-15
AU2932577A (en) 1979-04-12
SE7711094L (sv) 1978-04-06
NZ185341A (en) 1979-06-19
AU512101B2 (en) 1980-09-25
FR2367079A1 (fr) 1978-05-05
DK438577A (de) 1978-04-06
JPS5346952A (en) 1978-04-27
FI58779B (fi) 1980-12-31
DK142707B (da) 1980-12-29
US4150127A (en) 1979-04-17
NO773381L (no) 1978-04-06
IL53058A0 (en) 1977-12-30
FI772900A7 (fi) 1978-04-06
NL7710939A (nl) 1978-04-07
ES462882A1 (es) 1978-12-16

Similar Documents

Publication Publication Date Title
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
ATA932977A (de) Verfahren zur herstellung einer materialbahn
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362363B (de) Verfahren zur herstellung neuer azetidinole
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT358831B (de) Verfahren zur herstellung einer materialschicht
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
ATA705277A (de) Verfahren zur herstellung neuer steroidverbindun- gen mit 19-staendiger sauerstoffunktion
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
AT351762B (de) Verfahren zur herstellung neuer thermo- plastischer terpolymerisate
DD136135A5 (de) Verfahren zur herstellung neuer pyrrolidinverbindungen
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT339253B (de) Verfahren zur herstellung eines reinen ceroxids
AT360971B (de) Verfahren zur herstellung neuer alkinole
AT361527B (de) Verfahren zur herstellung eines verbundwerk- stoffes
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
DD128972A1 (de) Verfahren zur herstellung einer schuettgutkippe mit bandabsetzern
AT355239B (de) Verfahren zur herstellung neuer d-homosteroide
AT348162B (de) Verfahren zur herstellung neuer d-homosteroide
ATA590279A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
DD126089A5 (de) Verfahren zur herstellung einer trockendessert-mischung